BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 4210459)

  • 1. A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients.
    Gross HS
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):696-705. PubMed ID: 4210459
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind comparison of pimozide vs. trifluoperazine in schizophrenic outpatients.
    Claghorn JL
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):1005-9. PubMed ID: 4214658
    [No Abstract]   [Full Text] [Related]  

  • 3. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, I.
    Amin MM; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1977 Jul; 13(3):15-7. PubMed ID: 329323
    [No Abstract]   [Full Text] [Related]  

  • 4. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, II.
    Vergara L; Amin MM; Ban TA
    Psychopharmacol Bull; 1977 Jul; 13(3):17-9. PubMed ID: 329324
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients.
    Kolivakis T; Azim H; Kingstone E
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):998-1004. PubMed ID: 4214674
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind comparison of pimozide with carpipramine in schizophrenic patients.
    Kudo Y
    Acta Psychiatr Belg; 1972 Nov; 72(6):685-97. PubMed ID: 4606115
    [No Abstract]   [Full Text] [Related]  

  • 7. Pimozide in chronic schizophrenic outpatients.
    Clark ML; Huber WK; Hill D; Wood F; Costiloe JP
    Dis Nerv Syst; 1975 Mar; 36(3):137-41. PubMed ID: 1112170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled trial of pimozide and trifluoperazine in chronic schizophrenic syndromes.
    Andersen K; d'Elia G; Hållberg B; Perris C; Rapp W; Román G
    Acta Psychiatr Scand Suppl; 1974; 249():43-64. PubMed ID: 4608709
    [No Abstract]   [Full Text] [Related]  

  • 9. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
    Wilson LG; Roberts RW; Gerber CJ; Johnson MH
    J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter multidimensional study of some new longacting neuroleptic drugs.
    Acta Psychiatr Scand Suppl; 1974; 249():1-134. PubMed ID: 4608507
    [No Abstract]   [Full Text] [Related]  

  • 11. A twelve month comparison of penfluridol and trifluoperazine in chronic schizophrenic outpatients.
    Donlon PT; Meyer JE
    J Clin Psychiatry; 1978 Jun; 39(6):582-3, 686-8. PubMed ID: 350861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to trifluoperazine-amobarbital in outpatients with anxiety. (A double-blind, placebo-controlled study).
    Guthrie MB; Free SM
    Dis Nerv Syst; 1969 Mar; 30(3):195-200. PubMed ID: 4886703
    [No Abstract]   [Full Text] [Related]  

  • 13. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
    Knight RG; Harrison A
    N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind comparison of molindone and trifluoperazine in the treatment of acute schizophrenia.
    Simpson GM; Amin M; Edwards JG
    J Clin Pharmacol New Drugs; 1971; 11(3):227-36. PubMed ID: 4946101
    [No Abstract]   [Full Text] [Related]  

  • 15. Pimozide: a comparative study in the treatment of chronic schizophrenic patients.
    Pinard G; Prénoveau Y; Fliesen W; Elie R; Bielmann P; Lamontagne Y; Tétreault L
    Int J Clin Pharmacol; 1972 Apr; 6(1):22-7. PubMed ID: 4558783
    [No Abstract]   [Full Text] [Related]  

  • 16. Effective short-term treatment of generalized anxiety disorder with trifluoperazine.
    Mendels J; Krajewski TF; Huffer V; Taylor RJ; Secunda S; Schless A; Sebastian JA; Semchyshyn G; Durr MJ; Melmed AS
    J Clin Psychiatry; 1986 Apr; 47(4):170-4. PubMed ID: 3514583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pimozide and the social behavior of schizophrenics.
    Lapierre YD; Lavallee J
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):181-88. PubMed ID: 809233
    [No Abstract]   [Full Text] [Related]  

  • 18. Metiapine: a double-blind evaluation in chronic schizophrenic patients.
    Gallant DM; Bishop MP; Guerrero-Figueroa R
    Curr Ther Res Clin Exp; 1971 Dec; 13(12):734-6. PubMed ID: 5001741
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors determining patient tenure on a 3-year double-blind investigation of pimozide versus fluphenazine HCl.
    Abuzzahab FS; Zimmermann RL
    Adv Biochem Psychopharmacol; 1980; 24():547-50. PubMed ID: 7405675
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative short-term evaluation of penfluridol and trifluoperazine in chronic schizophrenia.
    Khorana AB; Patel Y
    Indian J Physiol Pharmacol; 1988; 32(4):293-8. PubMed ID: 3063660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.